Abstract
Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.
Keywords:
contrast agent; ferumoxytol; iron oxide; safety.
© 2016 Wiley Periodicals, Inc.
MeSH terms
-
Clinical Trials as Topic
-
Contrast Media / chemistry
-
Ferric Compounds / chemistry
-
Ferrosoferric Oxide / administration & dosage*
-
Ferrosoferric Oxide / adverse effects
-
Ferrosoferric Oxide / chemistry
-
Gadolinium / chemistry
-
Humans
-
Iodine / chemistry
-
Macrophages / metabolism
-
Magnetic Resonance Imaging*
-
Neoplasm Metastasis
-
Neoplasms / diagnostic imaging*
-
Neoplasms / pathology*
-
Patient Safety
-
Perfusion
Substances
-
Contrast Media
-
Ferric Compounds
-
ferric oxide
-
Iodine
-
Gadolinium
-
Ferrosoferric Oxide